Cost should be the principal determinant of choice of erythropoiesis-stimulating agent in chronic haemodialysis patients.
| Data(s) |
01/09/2007
|
|---|---|
| Identificador |
http://dx.doi.org/10.1159/000106507 http://www.scopus.com/inward/record.url?scp=34548455346&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Maxwell , A 2007 , ' Cost should be the principal determinant of choice of erythropoiesis-stimulating agent in chronic haemodialysis patients. ' Nephron. Clinical practice , vol 107(1) , no. 1 , pp. c14-9-c19 . DOI: 10.1159/000106507 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2727 #Nephrology |
| Tipo |
article |
